| |
| |
|
| Insider
Information: |
Levin Jeremy M |
| Relationship: |
CEO, Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
3,660,404 |
|
|
Indirect Shares
|
35,461 |
|
|
| Direct
Value |
$13,171,268 |
|
|
|
Indirect Value
|
$109,929 |
|
|
| Total
Shares |
3,695,865 |
|
|
| Total
Value |
$13,281,197 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -12.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP Strat Transactions |
2011-10-01 |
43,689 |
|
0 |
Premium* |
|
|
Ovid Therapeutics Inc. |
OVID |
CEO, Director |
2024-03-18 |
3,616,715 |
2024-03-18 |
35,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • – |
2024-03-18 |
4 |
B |
$2.76 |
$50,364 |
D/D |
18,248 |
3,616,715 |
2.81 |
% |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • – |
2023-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,146,550 |
3,598,467 |
0 |
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • • |
2020-08-28 |
4 |
B |
$5.84 |
$49,570 |
D/D |
8,488 |
5,792,530 |
3.23 |
% |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • • |
2019-10-08 |
4 |
B |
$2.50 |
$150,000 |
D/D |
60,000 |
4,736,529 |
3.23 |
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • – |
2019-09-20 |
4/A |
GD |
$0.00 |
$0 |
I/I |
465,116 |
0 |
0 |
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • • |
2019-02-22 |
4 |
B |
$2.00 |
$150,000 |
D/D |
75,000 |
4,676,529 |
3.23 |
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • • |
2017-08-25 |
4 |
B |
$7.15 |
$109,638 |
D/D |
15,334 |
4,601,529 |
3.23 |
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • • |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
I/I |
35,461 |
35,461 |
0 |
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEO |
• • • |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
400,150 |
4,586,195 |
0 |
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEOOfficer |
• • • |
2017-05-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
465,116 |
|
- |
|
| OVID |
Ovid Therapeutics Inc. |
CEOOfficer |
• • • |
2017-05-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,186,045 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-10-01 |
4 |
D |
$31.38 |
$147,612 |
D/D |
(4,704) |
43,689 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
48,393 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-04 |
4 |
D |
$26.43 |
$14,959 |
D/D |
(566) |
38,393 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,397 |
38,959 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-03 |
4 |
D |
$26.14 |
$21,383 |
D/D |
(818) |
37,562 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,019 |
38,380 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,307 |
37,245 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
84 |
37,329 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-02 |
4 |
D |
$25.39 |
$24,578 |
D/D |
(968) |
36,361 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,240) |
34,938 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,944 |
40,178 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2010-10-01 |
4 |
D |
$27.28 |
$113,157 |
D/D |
(4,148) |
26,357 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat Transactions |
• – – |
2010-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
30,505 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Strat TransactionsOfficer |
• – – |
2010-05-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,505 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
